In a Prism News article, Maria Rodriguez, M.D., advocates for the inclusion of postpartum care through Emergency Medicaid for undocumented immigrants: “Allowing people who are low income to enroll in Medicaid regardless of citizenship status would be the right thing to do — both from a health and human rights perspective, but also from a program perspective ... Restricting access to preventative care is foolish: it ends up in worse health outcomes and usually costs losses for the program.”

In a The Hill article that explores whether cannabis reduces anxiety, Devan Kasagara, M.D., says: “In terms of anxiety, the bottom line is that there is just a lot more that we have to learn about it. We really don’t know.”

OHSU Health and others sponsored an American Heart Association’s fund-raising event to reduce barriers to health care access and quality.

In a story about St. Charles Health’s decision to stop providing planned surgeries in Prineville, Robert Duehmig says there are multiple challenges facing rural health and “Reducing surgical services in any rural community typically requires patients to drive longer in order to receive necessary health services. This creates additional barriers to accessing care, which can cause people to either delay seeking treatment or not receive treatment, and can also increase poor health outcomes in the affected area."

Kathleen Carlson, Ph.D., Ben Hoffman, M.D., and Roy Moore with Portland Opportunities Industrialization Center join Sen. Ron Wyden at an OHSU roundtable discussion aimed at curbing gun violence.

The Cancer Letter covered the election of Lisa Coussens, Ph.D., to the National Academy of Sciences.

A Lund Report story on patients who pay for Medicare Advantage plans but can’t reach mental health providers cites an OHSU study that found as many as nearly six in every 10 providers listed in Oregon Health Plan directories did not see patients in the Medicaid-funded plan.

Anna Bar, M.D., shares insight on the value of transparency and relationship building between clinicians practicing dermatologic care and Mohs surgeons in advance of American College of Mohs Surgery Meeting.

David Spencer, M.D., discusses the importance of patient safety in a first-in-human trial of NRTX-1001 GABAergic interneuron cell therapy for focal epilepsy.

In a piece describing how activists and organizers respond to discouragement, Blair Peters, M.D., says: “When it feels like change is not happening, or is moving in the wrong direction, I choose to see the change around me.”